What Are Biomarkers and Why Do They Matter to Bladder Cancer Patients?

Bladder Cancer Matters

English - February 22, 2022 15:36 - 45 minutes - 40.4 MB - ★★★★★ - 28 ratings
Medicine Health & Fitness cancersurvivorship bladdercancer cancerresearch Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: What the Cancer Experience Registry Means to Bladder Cancer Patients with Dr. Kimberly Papay Rogers

Next Episode: What's the Connection Between Bladder Cancer and Environmental Exposure?

In Episode 22 of Bladder Cancer Matters, host Rick Bangs talks with Drs. Phil Abbosh and Max Kates about bladder cancer biomarkers. Dr. Abbosh is a urologic oncologist at the Fox Chase Cancer Center in Philadelphia. Dr. Kates is an assistant professor of urology and oncology with the Brady Urological Institute at Johns Hopkins in Baltimore.

Rick and Drs. Abbosh and Kates talk about what biomarkers are and how they are relevant to bladder cancer. A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition like bladder cancer.

Click here to read the transcript.